BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32928072)

  • 1. A therapeutic concept to resolve a possible coronary desaturation under Ecpella support and maximize the potential for myocardial recovery: combination of veno-arteriovenous extracorporeal membrane oxygenation and Impella (VAVEcpella).
    Ushijima T; Sonoda H; Tanoue Y; Shiose A
    Perfusion; 2021 Jul; 36(5):535-537. PubMed ID: 32928072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of veno-arterial extracorporeal membrane oxygenation combined with Impella (ECpella) therapy in acute coronary syndrome with cardiogenic shock.
    Shibasaki I; Masawa T; Abe S; Ogawa H; Takei Y; Tezuka M; Seki M; Kato T; Watanabe R; Koshiji N; Saitou S; Ogata K; Haruyama Y; Toyoda S; Fukuda H
    J Cardiol; 2022 Aug; 80(2):116-124. PubMed ID: 35288000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of concomitant use of veno-arterial extracorporeal membrane oxygenation support with Impella in cardiogenic shock: From percutaneous femoral Impella to axillary Impella 5.5.
    Isath A; Ohira S; Levine A; Lanier GM; Pan S; Aggarwal-Gupta C; Mason I; Gregory V; Spielvogel D; Gass AL; Kai M
    Artif Organs; 2023 Aug; 47(8):1404-1412. PubMed ID: 37335815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful weaning from veno-arterial ECMO and Impella2.5 by veno-venous and arterial ECMO (v-ECPELLA) for a patient with acute myocardial infarction complicated by severe lung injury.
    Shimizu S; Shimano M; Shibata Y; Hanaki Y; Kamiya H; Morimoto R; Okumura T; Murohara T
    J Cardiol Cases; 2020 Sep; 22(3):103-106. PubMed ID: 32884588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venoarterial Extracorporeal Membrane Oxygenation With Concomitant Impella Versus Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock.
    Vallabhajosyula S; O'Horo JC; Antharam P; Ananthaneni S; Vallabhajosyula S; Stulak JM; Dunlay SM; Holmes DR; Barsness GW
    ASAIO J; 2020 May; 66(5):497-503. PubMed ID: 31335363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impella as unloading strategy during VA-ECMO: systematic review and meta-analysis.
    Fiorelli F; Panoulas V
    Rev Cardiovasc Med; 2021 Dec; 22(4):1503-1511. PubMed ID: 34957789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock.
    Patel SM; Lipinski J; Al-Kindi SG; Patel T; Saric P; Li J; Nadeem F; Ladas T; Alaiti A; Phillips A; Medalion B; Deo S; Elgudin Y; Costa MA; Osman MN; Attizzani GF; Oliveira GH; Sareyyupoglu B; Bezerra HG
    ASAIO J; 2019 Jan; 65(1):21-28. PubMed ID: 29489461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implication of risk scoring systems in patients with cardiogenic shock supported by ECMO and Impella.
    Nakamura M; Imamura T; Hori M; Yokoyama S; Doi T; Fukahara K; Kinugawa K
    J Artif Organs; 2021 Sep; 24(3):372-376. PubMed ID: 33392863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impella Motor Current Amplitude Reflects the Degree of Left Ventricular Unloading under ECPELLA Support.
    Unoki T; Saku K; Kametani M; Konami Y; Taguchi E; Sawamura T; Nakao K; Sakamoto T
    Int Heart J; 2022; 63(6):1187-1193. PubMed ID: 36450558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery.
    Sayed S; Schimmer C; Shade I; Leyh R; Aleksic I
    J Cardiothorac Surg; 2017 May; 12(1):38. PubMed ID: 28532425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic thrombosis with visceral malperfusion during circulatory support with a combination of Impella and extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock.
    Yamana F; Domae K; Kawasumi R; Sakamoto T; Hata M; Shirakawa Y; Masai T; Sawa Y
    J Artif Organs; 2023 Dec; 26(4):330-334. PubMed ID: 36705891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful Use of Percutaneous Left Ventricular Assist Device( Impella) and Veno Artery Extracorporeal Membrane Oxygenation( VA-ECMO) for Ischemic Cardiogenic Shock;Report of a Case].
    Tadakoshi M; Ohashi T; Kageyama S; Kojima A; Oshiro N; Kodani N; Kawasumi R; Yamaguchi T
    Kyobu Geka; 2019 Feb; 72(2):120-123. PubMed ID: 30772876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Rescue Use of ECPELLA for Sepsis-Induced Cardiogenic Shock Followed by Mitral Valve Replacement.
    Nakamura M; Imamura T; Oshima A; Sobajima M; Yokoyama S; Doi T; Fukahara K; Kinugawa K
    Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis Comparing Venoarterial Extracorporeal Membrane Oxygenation With or Without Impella in Patients With Cardiogenic Shock.
    Bhatia K; Jain V; Hendrickson MJ; Aggarwal D; Aguilar-Gallardo JS; Lopez PD; Narasimhan B; Wu L; Arora S; Joshi A; Tomey MI; Mahmood K; Qamar A; Birati EY; Fox A
    Am J Cardiol; 2022 Oct; 181():94-101. PubMed ID: 35999070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Management of ECPELLA.
    Nakamura M; Imamura T
    Int Heart J; 2020 Nov; 61(6):1094-1096. PubMed ID: 33116023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term use of "ECMELLA" in the context of fulminant eosinophilic myocarditis with cardiogenic shock.
    Bohné M; Chung DU; Tigges E; van der Schalk H; Waddell D; Schenker N; Willems S; Klingel K; Kivelitz D; Bahlmann E
    BMC Cardiovasc Disord; 2020 Dec; 20(1):519. PubMed ID: 33302874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased and continuous coronary arterial flow was induced by LV uncoupling condition using combined treatment of a microaxial heart pump and venoarterial extracorporeal membrane oxygenation.
    Kametani M; Yamada M; Horibata Y; Sakamoto T; Unoki T
    Physiol Rep; 2021 Oct; 9(20):e15084. PubMed ID: 34676674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total percutaneous biventricular assist device implantation for fulminant myocarditis.
    Tominaga Y; Toda K; Miyagawa S; Yoshioka D; Kainuma S; Kawamura T; Kawamura A; Nakamoto K; Sakata Y; Sawa Y
    J Artif Organs; 2021 Jun; 24(2):254-257. PubMed ID: 32748246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs. without left ventricular unloading by Impella: a systematic review and meta-analysis.
    Cappannoli L; Galli M; Zito A; Restivo A; Princi G; Laborante R; Vergallo R; Romagnoli E; Leone AM; Aurigemma C; Massetti M; Sanna T; Trani C; Burzotta F; Savarese G; Crea F; D'Amario D
    Eur Heart J Qual Care Clin Outcomes; 2023 Jun; 9(4):358-366. PubMed ID: 36370449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled nitric oxide for ECPELLA management in fulminant myocarditis complicated with severe right ventricular dysfunction: A case report.
    Oki T; Ikeda Y; Ishii S; Ako J
    J Cardiol Cases; 2022 Aug; 26(2):104-107. PubMed ID: 35949567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.